Application of a multivariant, caucasian-specific, genotyped donor panel for performance validation of MDmulticard, ID-system®, and Scangel® RhD/ABO serotyping

Transfusion Medicine and Hemotherapy

Volumn 36, Issue 3, 2009, Pages 219-225

  Gassner, Christoph ^a,g   Rainer, Esther ^a   Pircher, Elfriede ^a   Markut, Lydia ^a   Körmöczi, Günther F ^b   Jungbauer, Christof ^c   Wessin, Dietmar ^d   Klinghofer, Roswitha ^e   Schennach, Harald ^a   Schwind, Peter ^f   Schönitzer, Diether ^a  

^a Blood Transfusion and Immunological Department   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c Austrian Red Cross Blood Donation Center   (Austria)

^d Medical Central Laboratory   (Austria)

^e GENERAL HOSPITAL KLAGENFURT   (Austria)

^f Medion Diagnostics AG   (Switzerland)

^g Zentralinstitut für Bluttransfusion und Immunologische Abteilung   (Austria)

Author keywords

ABO blood group; Blood groups; DNA; Genotyping; Kell determination; Molecular blood group typing; Red blood cell antigens; Rh phenotyping; Serological typing

Indexed keywords

RHESUS D ANTIGEN;

ARTICLE; BLOOD ANALYSIS; BLOOD DONOR; BLOOD GROUP ABO SYSTEM; BLOOD GROUP RHESUS SYSTEM; BLOOD GROUP TYPING; BLOOD SAMPLING; CAUCASIAN; CONTROLLED STUDY; GENETICS; GENOTYPE; HUMAN; PHENOTYPE; SENSITIVITY AND SPECIFICITY; SEROTYPING; VALIDATION STUDY;

EID: 67650227473     PISSN: 16603796     EISSN: None     Source Type: Journal    
DOI: 10.1159/000215935     Document Type: Article

References (26)

1. Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices.
2. Entscheidung der Kommission vom 7. Mai 2002 über Gemeinsame Technische Spezifikationen für In-Vitro-Diagnostika (Bekannt gegeben unter Ak-tenzeichen K(2002) 1344)(Text von Bedeutung für den EWR)(2002/364/EG)
3. Yamamoto F, Clausen H, White T, Marken J, Hakomori S: Molecular genetic basis of the histo-blood group ABO system. Nature 1990;345:229-233.
4. Colin Y, Chérif-Zahar B, Le Van Kim C, Raynal V, Van Huffel V, Cartron JP: Genetic basis of the RhD-positive and RhD-negative blood group polymorphism as determined by Southern analysis. Blood 1991;78:2747-2752.
5. Stratton F: A new Rh allelomorph. Nature 1946; 4001:25.
6. Wagner FF, Gassner C, Müller TH, Schönitzer D, Schunter F, Flegel WA: Molecular basis of weak D phenotypes. Blood 1999;93:385-393.
7. Müller TH, Wagner FF, Trockenbacher A, Eicher NI, Flegel WA, Schönitzer D, Schunter F, Gassner C: PCR screening for common weak D types shows different distributions in three Central European populations. Transfusion 2001;41:45-52.
8. Shao CP, Maas JH, Su YQ, Köhler M, Legler TJ: Molecular background of Rh D-positive, D-nega-tive, D(el) and weak D phenotypes in Chinese. Vox Sang 2002;83:156-161.
9. Lin IL, Shih MC, Hsieh MH, Liu TC, Chang SE, Lin CL, Chang JG: Molecular basis of weak D in Taiwanese. Ann Hematol 2003;82:617-620.
10. Daniels G: Human Blood Groups, 2nd ed. Oxford, Blackwell Science, 2002.
11. Tippett P, Sanger R: Observations on subdivisions of the Rh antigen D. Vox Sang 1962;7:9-13.
12. Tippett P, Sanger R: Further observations on subdivisions of the Rh antigen Dtsch Ärztl Lab 1977;23: 476-480.
13. Körmöczi GF, Gassner C, Shao CP, et al: A comprehensive analysis of DEL types: partial DEL individuals are prone to anti-D alloimmunization. Transfusion 2005;45:1561-1567.
14. Avent ND, Reid ME: The Rh blood group system: a review. Blood 2000;95:375-387.
15. Flegel WA, Wagner FF: The frequency of RHD protein variants in Caucasians. Transfus Clin Biol 1996;3(suppl):10s.
16. Wagner FF, Eicher NI, Jørgensen JR, Lonicer CB, Flegel WA. DNB: a partial D with anti-D frequent in Central Europe. Blood 2002;100:2253-2256.
17. Gassner C, Doescher A, Drnovsek TD, Rozman P, Eicher NI, Legler TJ, Lukin S, Garritsen H, Kleinrath T, Egger B, Ehling R, Körmöczi GF, Kilga-Nogler S, Schoenitzer D, Petershofen EK: Presence of RHD in serologically D-, C/E+ individuals: a European multicenter study. Transfusion. 2005;45:527-538.
18. Database Red Blood Cells (RBC) of the National Center of Biotechnology Information homepage at http://www.ncbi.nlm.nih.gov. December 2008.
19. Wagner FF, Frohmajer A, Ladewig B, Eicher NI, Lonicer CB, Müller TH, Siegel MH, Flegel WA: Weak D alleles express distinct phenotypes. Blood 2000;95:2699-2708.
20. Körmöczi GF, Förstemann E, Gabriel C, Mayr WR, Schönitzer D, Gassner C: Novel weak D types 31 and 32: adsorption-elution- supported D antigen analysis and comparison to prevalent weak D types. Transfusion 2005;45:1574-1580.
21. Beckers EAM, Faas BHW, Von dem Borne AEGK, Overbeeke MAM, Van Rhenen DJ, van der Schoot CE: The R0HarRh:33 phenotype results from substitution of exon 5 of the RHCE gene by the corresponding exon of the RHD gene. Br J Haematol 1996;92:751-757.
22. Schwind P, Lōster K: Point-of-care multi-parameter typing of 10 blood groups with stable end-point. Transfusion 2004;44(suppl 9):121A.
23. Lapierre Y, Rigal D, Adam J, Josef, D, Meyer F, Greber S, Drot C: The gel test: a new way to detect red cell antigen-antibody reactions. Transfusion 1990; 30:109-113.
24. Frohn C, Dūmbgen L, Brand JM, Görg S, Luhm J, Kirchner H: Probability of anti-D development in D- patients receiving D+ RBCs. Transfusion 2003; 43:893-898.
25. von Zabern I, Flegel WA. IVS5-38del4 deletion in the RHD gene does not cause a DEL phenotype: relevance for RHD alleles including DFR-3. Transfusion. 2007;47:1552-1555.
26. Frame T, Carroll T, Korchagina E, Bovin N, Henry S: Synthetic glycolipid modification of red blood cell membranes. Transfusion 2007;47:876-882.